You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 8, August 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (139)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Endophthalmitis After Filtering Surgery With Mitomycin

David S. Greenfield, MD; Ivan J. Suñer, MD; Michael P. Miller, MD; Tracy A. Kangas, MD, PhD; Paul F. Palmberg, MD, PhD; Harry W. Flynn, Jr, MD

Arch Ophthalmol. 1996;114(8):943-949.


Abstract

Objective
To identify the incidence, causative organisms, and clinical outcomes of eyes with bleb-associated endophthalmitis after glaucoma filtering procedures with adjunctive mitomycin.

Methods
Retrospective analysis of 773 consecutive eyes that underwent glaucoma filtering surgery at the Bascom Palmer Eye Institute, Miami, Fla. The course of 609 eyes from 485 patients with a minimum of 3 months of follow-up were reviewed.

Results
Mean follow-up was 16.0±11.5 months (range, 3-48 months). Of the 609 eyes, 13(2.1%) developed bled-associated endophthalmitis an average of 18.5±13.2 months after surgery (range, 1-45 months). The incidence of bleb-associated endophthalmitis was significantly greater after inferior trabeculectomy (7.8% per patient-year) than after superior trabeculectomy (1.3% per patient-year) by Kaplan-Meier estimates (P=.02, log rank test). The cumulative incidence was 13% for inferior limbal blebs and 1.6% for superior limbal blebs. Nine (69.2%) of the 13 eyes were culture positive. Streptococcus sanguis and Haemophilus influenzae (6/13 [46.2%]) were the most frequent causative organisms. The mean increase in intraocular pressure after endophthalmitis treatment was 1.2 mm Hg, with a mean decrease in visual acuity of 1.42 log MAR units. Eight (61.5%) of the 13 eyes had a final acuity of 20/400 or better.

Conclusions
The incidence of bleb-associated endophthalmitis after guarded filtering surgery performed with adjunctive mitomycin is higher than the reported rate in eyes undergoing filtering surgery without the use of antifibrotic agents (0.2%-1.5%). Inferior limbal trabeculectomy carries the highest risk of infection. Eyes with mitomycin blebs maintained excellent filtration capacity. However, after treatment of the infection, the visual outcomes were generally poor.



Author Affiliations

From the Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami (Fla) School of Medicine. Dr Greenfield is now with The New York (NY) Eye and Ear Infirmary. The authors have no proprietary interest in any of the materials presented in this report.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial
Cantor et al.
Br J Ophthalmol 2008;92:345-347.
ABSTRACT | FULL TEXT  

Control of Filtering Bleb Structure through Tissue Bioengineering: An Animal Model
Chen et al.
IOVS 2006;47:5310-5314.
ABSTRACT | FULL TEXT  

The safety and efficacy of combined phacoemulsification and trabeculectomy with releasable sutures
Stark et al.
Br J Ophthalmol 2006;90:146-149.
ABSTRACT | FULL TEXT  

Prevalence of Open-Angle Glaucoma Among Adults in the United States
The Eye Diseases Prevalence Research Group
Arch Ophthalmol 2004;122:532-538.
ABSTRACT | FULL TEXT  

Outcomes of bleb excision and conjunctival advancement for leaking or hypotonous eyes after glaucoma filtering surgery
Tannenbaum et al.
Br J Ophthalmol 2004;88:99-103.
ABSTRACT | FULL TEXT  

Posttrabeculectomy Endophthalmitis Caused by Moraxella nonliquefaciens
Laukeland et al.
J. Clin. Microbiol. 2002;40:2668-2670.
ABSTRACT | FULL TEXT  

Should we vaccinate for glaucoma surgery?
Seemongal-Dass and James
Br J Ophthalmol 2002;86:479-480.
FULL TEXT  

Apoptosis Gene Expression and Death Receptor Signaling in Mitomycin-C-Treated Human Tenon Capsule Fibroblasts
Crowston et al.
IOVS 2002;43:692-699.
ABSTRACT | FULL TEXT  

Incidence of Late-Onset Bleb-Related Complications Following Trabeculectomy With Mitomycin
DeBry et al.
Arch Ophthalmol 2002;120:297-300.
ABSTRACT | FULL TEXT  

Late-Onset Bleb-Related Panophthalmitis With Orbital Abscess Caused by Pseudomonas stutzeri
Lebowitz et al.
Arch Ophthalmol 2001;119:1723-1725.
FULL TEXT  

Penetration of Ofloxacin and Ciprofloxacin Into the Aqueous Humor of Eyes With Functioning Filtering Blebs: A Randomized Trial
Cantor et al.
Arch Ophthalmol 2001;119:1254-1257.
ABSTRACT | FULL TEXT  

Glaucoma Filtration Surgery using Amniotic Membrane Transplantation
Barton et al.
IOVS 2001;42:1762-1768.
ABSTRACT | FULL TEXT  

Risk Factors for Late-Onset Infection Following Glaucoma Filtration Surgery
Jampel et al.
Arch Ophthalmol 2001;119:1001-1008.
ABSTRACT | FULL TEXT  

Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure
Casson et al.
Br J Ophthalmol 2001;85:686-688.
ABSTRACT | FULL TEXT  

Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma
Manners et al.
Br J Ophthalmol 2001;85:159-163.
ABSTRACT | FULL TEXT  

Enhanced Short-Term Plasmid Transfection of Filtration Surgery Tissues
Angella et al.
IOVS 2000;41:4158-4162.
ABSTRACT | FULL TEXT  

Risk factors for development of post-trabeculectomy endophthalmitis
Lehmann et al.
Br J Ophthalmol 2000;84:1349-1353.
ABSTRACT | FULL TEXT  

S-Nitrosoglutathione Photolysis as a Novel Therapy for Antifibrosis in Filtration Surgery
Tannous et al.
IOVS 2000;41:749-755.
ABSTRACT | FULL TEXT  

Risk Factors for Glaucoma Filtering Bleb Infections
Soltau et al.
Arch Ophthalmol 2000;118:338-342.
ABSTRACT | FULL TEXT  

Sponge delivery variables and tissue levels of 5-fluorouracil
Wilkins et al.
Br J Ophthalmol 2000;84:92-97.
ABSTRACT | FULL TEXT  

Haemophilus influenzae associated scleritis
Sykes et al.
Br J Ophthalmol 1999;83:410-413.
ABSTRACT | FULL TEXT  

Prognosis of primary ab externo surgery for primary congenital glaucoma
Dietlein et al.
Br J Ophthalmol 1999;83:317-322.
ABSTRACT | FULL TEXT  

Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma
Azuara-Blanco et al.
Br J Ophthalmol 1999;83:151-156.
ABSTRACT | FULL TEXT  

Recurrent bleb infections
Waheed et al.
Br J Ophthalmol 1998;82:926-929.
ABSTRACT | FULL TEXT  

Late-Onset Bleb Leaks After Glaucoma Filtering Surgery
Greenfield et al.
Arch Ophthalmol 1998;116:443-447.
ABSTRACT | FULL TEXT  

Outcomes of Primary Trabeculectomy With the Use of Adjunctive Mitomycin
Scott et al.
Arch Ophthalmol 1998;116:286-291.
ABSTRACT | FULL TEXT  

Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment
Mochizuki et al.
Br J Ophthalmol 1997;81:877-883.
ABSTRACT | FULL TEXT  

Outpatient Treatment of Bleb Infection
Chen et al.
Arch Ophthalmol 1997;115:1124-1128.
ABSTRACT  

A Long-term Dose-Response Study of Mitomycin in Glaucoma Filtration Surgery
Robin et al.
Arch Ophthalmol 1997;115:969-974.
ABSTRACT  

Filtering Bleb Infection as a Complication of Orthokeratology
Gupta and Weinreb
Arch Ophthalmol 1997;115:1076-1076.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.